In a subsequent JCI publication, we reported that sFLT1 mediated the enhanced angiotensin II sensitivity and hypertension noted in preeclampsia by inhibiting VEGF-dependent endothelial nitric oxide synthase and nitric oxide production (11). This evidence concerns the gene VEGFA and preeclampsia.